(Q46764282)

English

Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

0 references

0 references

0 references

3

object named as

Manfred Uhr

1 reference

Europe PubMed Central

25 December 2017

2

object named as

Adam Wichniak

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

author name string

Dagmar A Schmid

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

Marcus Ising

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

Hans Brunner

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

Katja Held

6

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

Jutta C Weikel

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

Annette Sonntag

8

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

Axel Steiger

9

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

language of work or name

0 references

publication date

1 April 2006

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

Neuropsychopharmacology

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

31

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

832-844

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300923

0 references

Elevated nocturnal profiles of serum leptin in patients with depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

On the role of menopause for sleep-endocrine alterations associated with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

The effects of antidepressants on sleep in patients with depression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

The role of leptin receptor signaling in feeding and neuroendocrine function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Sleep enhances nocturnal plasma ghrelin levels in healthy subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Hypothalamic peptide modulation of EEG sleep in depression: a further application of the S-process hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Alpha-delta sleep.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

The corticosteroid receptor hypothesis of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

High-quality antidepressant discovery by understanding stress hormone physiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Minireview: ghrelin and the regulation of energy balance--a hypothalamic perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

5-Hydroxytryptamine-2 antagonist increases human slow wave sleep.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Changes in sleep electroencephalogram and nocturnal hormone secretion after administration of the antidyskinetic agent sarizotan in healthy young male volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Melatonin and psychiatry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Olanzapine increases plasma ghrelin level in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Tolerability and safety aspects of mirtazapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Morphine-like effects of clonidine on the EEG, slow wave sleep and behavior in the dog.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

A reconceptualization of EEG alpha activity as an index of arousal during sleep: all alpha activity is not equal.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

The role of alpha-2 receptors in the medial preoptic area in the regulation of sleep-wakefulness and body temperature.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Sexual diergism of baseline plasma leptin and leptin suppression by arginine vasopressin in major depressives and matched controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Effects of mirtazapine on sleep polygraphic variables in major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Mirtazapine, but not fluvoxamine, normalizes the blunted REM sleep response to clonidine in depressed patients: implications for subsensitivity of alpha(2)-adrenergic receptors in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Endocrinological effects of mirtazapine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Human sleep EEG following the 5-HT1A antagonist pindolol: possible disinhibition of raphe neuron activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Sleep and the hypothalamo-pituitary-adrenocortical system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Sleep and endocrine regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Serum ghrelin concentrations in patients receiving olanzapine or risperidone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Ghrelin induces adiposity in rodents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

The acute effects of the noradrenaline reuptake inhibitor Org 4428 on EEG sleep in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Reciprocal interactions between the GH axis and sleep

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Ghrelin causes hyperphagia and obesity in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

Electroencephalographic and psychometric assessment of the CNS effects of single doses of guanfacine hydrochloride (Estulic) and clonidine (Catapres).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

21 January 2018

5-HT2 receptors are partially involved in the relationship between renin release and delta relative power

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

7 January 2021

based on heuristic

inferred from DOI database lookup

An alpha 2 adrenoceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma ghrelin concentration and energy balance: overfeeding and negative energy balance studies in twins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the antidepressant Org 3770 on human sleep

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

7 January 2021

based on heuristic

inferred from DOI database lookup

The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

7 January 2021

based on heuristic

inferred from DOI database lookup

Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in EEG power density of non-REM sleep in depressed patients during treatment with trazodone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

7 January 2021

based on heuristic

inferred from DOI database lookup

Objective sleep quality of healthy older men and women is differentially disrupted by nighttime periodic blood sampling via indwelling catheter.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300923

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300923

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16237393

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46764282&oldid=2130307229"